WELLINGTON MANAGEMENT GROUP LLP
Position in FDMT — 4D Molecular Therapeutics, Inc.
CIK 902219
Boston, MA
Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,708,570
+$694,973 QoQ
Shares Held
128,464
+18.0% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 158 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 0%
Shared 70%
None 30%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. FDMT ranks #132 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in FDMT
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,708,570 | 128,464 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,013,597 | 108,872 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $976,889 | 130,252 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,177,233 | 135,470 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $799,330 | 247,471 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $987,443 | 177,279 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,796,513 | 166,190 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,766,527 | 179,444 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,404,983 | 169,648 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,656,422 | 180,475 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $2,198,750 | 172,722 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,055,346 | 169,084 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,017,119 | 175,516 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,790,235 | 260,704 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,137,771 | 265,892 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $854,239 | 122,384 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,850,445 | 122,384 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,747,115 | 261,947 | Shares | Defined | 2022-02-11 | |
| 2021-03-31 | $3,915,087 | 90,251 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,670,469 | 209,179 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||